Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-10-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-43905-1 |
| _version_ | 1797452844203245568 |
|---|---|
| author | Rania Zekry Gamal A. Omran Nashwa M. El-Gharbawy Rehab H. Werida |
| author_facet | Rania Zekry Gamal A. Omran Nashwa M. El-Gharbawy Rehab H. Werida |
| author_sort | Rania Zekry |
| collection | DOAJ |
| first_indexed | 2024-03-09T15:14:32Z |
| format | Article |
| id | doaj.art-5272b90e083c439abe7eefaa0109db85 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-09T15:14:32Z |
| publishDate | 2023-10-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-5272b90e083c439abe7eefaa0109db852023-11-26T13:10:04ZengNature PortfolioScientific Reports2045-23222023-10-011311210.1038/s41598-023-43905-1Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitusRania Zekry0Gamal A. Omran1Nashwa M. El-Gharbawy2Rehab H. Werida3Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour UniversityDepartment of Biochemistry, Faculty of Pharmacy, Damanhour UniversityDiabetes and Endocrinology Unit, Department of Internal Medicine, Tanta UniversityDepartment of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour Universityhttps://doi.org/10.1038/s41598-023-43905-1 |
| spellingShingle | Rania Zekry Gamal A. Omran Nashwa M. El-Gharbawy Rehab H. Werida Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus Scientific Reports |
| title | Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus |
| title_full | Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus |
| title_fullStr | Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus |
| title_full_unstemmed | Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus |
| title_short | Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus |
| title_sort | author correction comparative study of dapagliflozin versus glimepiride effect on insulin regulated aminopeptidase irap and interleukin 34 il 34 in patient with type 2 diabetes mellitus |
| url | https://doi.org/10.1038/s41598-023-43905-1 |
| work_keys_str_mv | AT raniazekry authorcorrectioncomparativestudyofdapagliflozinversusglimepirideeffectoninsulinregulatedaminopeptidaseirapandinterleukin34il34inpatientwithtype2diabetesmellitus AT gamalaomran authorcorrectioncomparativestudyofdapagliflozinversusglimepirideeffectoninsulinregulatedaminopeptidaseirapandinterleukin34il34inpatientwithtype2diabetesmellitus AT nashwamelgharbawy authorcorrectioncomparativestudyofdapagliflozinversusglimepirideeffectoninsulinregulatedaminopeptidaseirapandinterleukin34il34inpatientwithtype2diabetesmellitus AT rehabhwerida authorcorrectioncomparativestudyofdapagliflozinversusglimepirideeffectoninsulinregulatedaminopeptidaseirapandinterleukin34il34inpatientwithtype2diabetesmellitus |